PREDICTIVE BIOTECH SIGNS LETTER OF INTENT WITH IQVIA TO BEGIN CLINCIAL TRIAL FOR OSTEOARTHRITIS OF THE KNEE

By |2019-05-15T15:13:04-06:00May 14th, 2019|

PREDICTIVE BIOTECH SIGNS LETTER OF INTENT WITH IQVIA TO BEGIN CLINCIAL TRIAL FOR OSTEOARTHRITIS OF THE KNEE Company shifts focus of human cell and tissue products to biopharmaceuticals  SALT LAKE CITY (May 14, 2019) – Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for disease identification and subsequent [...]